Provectus Biopharmaceuticals (PVCT, $0.11) was one of top quarterly gainers, jumping +2 to $0.11 per share. A.I.dvisor analyzed 838 stocks in the Biotechnology Industry over the last three months, and discovered that of them (5) charted an Uptrend while of them (4) trended down.